Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.2% year on year to $10.97 billion. Its non-GAAP profit ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price target of $158.00. The company’s shares closed last ...

In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Abbott Laboratories (ABT – Research Report). The company’s shares opened today at $129.75.

Using the 2 Stage Free Cash Flow to Equity, Abbott Laboratories fair value estimate is US$152 With US$129 share price, Abbott Laboratories appears to be trading close to its estimated fair value ...

The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter ...

Abbott Laboratories will report earnings pre-market on January 22, with an earnings consensus of $1.04 per share. Abbott continues to execute growth businesses with excellent marketing and ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks discussed by Jim Cramer with insights on the DeepSeek AI sell-off. On the day that ...

A year after the American Academy of Pediatrics flagged what it described as "questionable marketing practices" by makers of formulas for older infants and toddlers, Abbott Laboratories is being ...

2025 Adjusted Operating Margin Forecast: 23.5% to 24% of sales. 2025 Adjusted Tax Rate Forecast: 16% to 17%. Abbott Laboratories (NYSE:ABT) achieved a 9.5% sales growth excluding COVID testing, ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks. In his recent appearance on CNBC’s Squawk on the Street, Jim Cramer started ...

Looking at the universe of stocks we cover at Dividend Channel, on 1/15/25, Abbott Laboratories (Symbol: ABT), AbbVie Inc (Symbol: ABBV), and Phillips Edison & Co Inc (Symbol: PECO) will all trade ...